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Direct maternal deaths attributable to HIV in the era
of antiretroviral therapy: evidence from three
population-based HIV cohorts with verbal autopsy
Clara Calverta, Milly Marstona, Emma Slaymakera,
Amelia C. Crampina,b, Alison J. Pricea,b, Nigel Kleinc,d,
Kobus Herbstd, Denna Michaele, Mark Urassae, Samuel J. Clarkf,
Carine Ronsmansg and Georges Reniersa,h
Objective: To assess whether HIV is associated with an increased risk of mortality from
direct maternal complications.
Design: Population-based cohort study using data from three demographic surveil-
lance sites in Eastern and Southern Africa.
Methods: We use verbal autopsy data, with cause of death assigned using the
InSilicoVA algorithm, to describe the association between HIV and direct maternal
deaths amongst women aged 20–49 years. We report direct maternal mortality rates by
HIV status, and crude and adjusted rate ratios comparing HIV-infected and uninfected
women, by study site and by ART availability. We pool the study-specific rate ratios
using random-effects meta-analysis.
Results: There was strong evidence that HIV increased the rate of direct maternal
mortality across all the study sites in the period ART was widely available, with the rate
ratios varying from 4.5 in Karonga, Malawi [95% confidence interval (CI) 1.6–12.6] to
5.2 in Kisesa, Tanzania (95% CI 1.7–16.1) and 5.9 in uMkhanyakude, South Africa
(95% CI 2.3–15.2) after adjusting for sociodemographic confounders. Combining these
adjusted results across the study sites, we estimated that HIV-infected women have 5.2
times the rate of direct maternal mortality compared with HIV-uninfected women (95%
CI 2.9–9.5).
Conclusion: HIV-infected women face higher rates of mortality from direct maternal
causes, which suggests that we need to improve access to quality maternity care for
these women. These findings also have implications for the surveillance of HIV/AIDS-
related mortality, as not all excess mortality attributable to HIV will be explicitly
attributed to HIV/AIDS on the basis of a verbal autopsy interview.
Copyright  2020 The Author(s). Published by Wolters Kluwer Health, Inc.
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Introduction
Early in the HIV epidemic, researchers noted the link
between HIV and maternal mortality [1–3]. In Malawi,
for example, the maternal mortality ratio tripled between
1980 and 1999, when the epidemic was growing [2].
Several studies have since documented that pregnant and
postpartum women living with HIV have around eight
times the risk of mortality compared with their
uninfected counterparts; [4,5] however, the excess
pregnancy-related mortality in women living with HIV
(WLHIV) remains poorly understood.
HIV may increase the risk of mortality in pregnant and
postpartum women through three main pathways. Firstly,
some HIV-attributable deaths are likely caused by HIV/
AIDS-related conditions, including pneumocystis pneu-
monia and tuberculosis. Pregnancy may accelerate HIV
disease progression because of pregnancy-associated
immunosuppression [6], although there is little epidemi-
ological evidence to support this [7,8]. Secondly, HIV, or
side effects of ART, may increase the risk or severity of
complications of pregnancy, including sepsis, haemor-
rhage and hypertensive diseases of pregnancy. Finally,
pregnant and postpartum WLHIV may have higher case-
fatality associated with direct maternal causes as they are
less likely to seek skilled assistance [9].
At the population level, the increased risk of direct
maternal mortality amongst WLHIV may be offset by
lower levels of fertility associated with HIV infection
[10,11], but Byass et al. [12] found that mortality rates
from direct maternal causes were four times higher
among WLHIV than HIV-negative women. These
estimates were based on pre-ART data in Eastern and
Southern Africa. This articles provides a timely update,
given the rapid expansion of ART, which has large
mortality-inhibiting effects. The impact of ARTon direct
maternal mortality is not clear. ART may reduce the risk
of some complications (e.g. sepsis) and increase the
likelihood of women seeking skilled assistance by
increasing contact with healthcare services or reducing
stigma. However, it is likely to have no, or possibly an
adverse, impact on other direct maternal complications.
We explore the association between HIV and direct
maternal causes of death amongst women, focusing on
the period since ART became widely available.
Methods
Study sites
Three members of the network for Analysing Longitu-
dinal Population-based HIV/AIDS data in Africa
(ALPHA) contributed data for this analysis: [13] Karonga
in Malawi, Kisesa in Tanzania and uMkhanyakude in
South Africa. These partners completed multiple years of
surveillance in their Demographic Surveillance Systems
(DSS), conducted repeated population-based HIV
serosurveys and, where a death was identified, adminis-
tered a verbal autopsy interview in which a caregiver/
relative of the deceased reports signs and symptoms
preceding the death [14]. All three members have
conducted at least 5 years of HIV serosurveys and over
80% of the deaths identified in the DSS can be linked to a
verbal autopsy. Data were available from 2007 to 2012 in
Karonga, 1994–2014 in Kisesa and 2004–2014 in
uMkhanyakude. More details about the data collection
procedures are given in the Supplementary Material,
http://links.lww.com/QAD/B733 and the cohort pro-
files describing the respective DSS [15–17].
Data preparation
From each DSS, we extracted information on residency
episodes, the events terminating residency episodes
(death, out migration), HIV test dates and results and,
for deaths, the signs and symptoms reported in a verbal
autopsy.
The exposure of interest was person-time with and
without HIV. HIV testing dates and results were linked to
basic demographic (for example, age) and residency
information, including DSS entry and exit dates, to
provide the denominator population. Several assumptions
were made when assigning person-time by HIV status.
Time preceding the first HIV test was classified as
unknown, as was person-time that occurred more than
5 years after the last HIV-negative test. Using a 5-year
cut-off (as used by Byass et al. [12]) allowed for the
estimation of mortality rates in HIV-negative individuals,
but the exposure time was sufficiently short that increased
mortality among seroconverters did not introduce bias.
All person-time after an HIV-positive test result was
treated as positive.
Person-time was additionally categorized by other key
factors: education (none, some primary, some secondary
and unknown); residence (urban, peri-urban and rural in
Kisesa and uMkhanyakude, and by distance from a trading
centre in Karonga); age; calendar period and whether
ARTwas available (none, early ARTor widely available).
‘Early ART’ is from when ART first became available at
one government health facility and ‘widely available’ from
when ART first became available at all local health
facilities designated as ART providers under national
guidelines [18]. Further details of these dates are provided
in Supplementary Table 1, http://links.lww.com/QAD/
B733. Kisesa was the only study site contributing data
from the pre-ARTera, and data for the early ART period
were also available in uMkhanyakude. We restricted the
analysis to women aged 20–49 years because of the
differing fertility effects linked with HIVat younger ages.
Causes of death were ascertained from the signs and
symptoms reported in the verbal autopsy using the
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InSilicoVA tool (version 1.2.5 in R 3.5.1) [19].
InSilicoVA calculates a distribution of probabilities
associated with each cause of death at the individual
level and a distribution of counts of deaths for each cause
at the population (or sub-population) level. We generated
estimates for sub-populations defined by HIV status at
time of death. Individual-level cause-specific probabilities
of dying were then used to assign a cause of death for each
individual. This was the cause of death with the highest
probability. Where no cause had a probability greater than
0.4, the cause was assigned as indeterminate.
The outcome for this analysis was direct maternal deaths,
defined by WHO as deaths during pregnancy or up to 42
days postpartum resulting from ‘obstetric complications
of the pregnancy state (pregnancy, labour and the
puerperium), from interventions, omissions, incorrect
treatment or from a chain of events resulting from any of
the above’ [20]. The cause categories from InSilicoVA
that most closely correspond to this definition, and were
therefore combined to give the outcome, are: ectopic
pregnancy, abortion-related death, pregnancy-induced
hypertension, obstetric haemorrhage (including ruptured
uterus), obstructed labour, pregnancy-related sepsis, and
anaemia of pregnancy. The ICD-10 equivalent codes for
each of these categories is provided in Supplementary
Table 2, http://links.lww.com/QAD/B733. The key
question in the verbal autopsy tool to identify pregnancy-
related deaths asks whether any woman who died was
pregnant or within 42 days of delivery, but we cannot rule
out that some women who died beyond 42 days
postpartum would be classified as a direct maternal death
through the algorithm. A further category ‘other/
unspecified maternal causes’ was not included in our
outcome as it includes indirect maternal causes of death
‘from previous existing disease or disease that developed
during pregnancy and which was not due to direct
obstetric causes, but which was aggravated by physiologic
effects of pregnancy’ [20]. For a sensitivity analysis, we
also used a more restrictive definition of direct maternal
causes excluding anaemia, as risk of anaemia is elevated
with HIV.
Statistical methods
We calculated the number of deaths in the DSS that
received a verbal autopsy, and the percentage of deaths
attributed to direct maternal deaths, stratified by HIV
status. InSilicoVA generated cause-specific mortality
fractions for each sub-population (HIV status). The
methods to produce these estimates are described in detail
elsewhere [19].
Using survival analysis, the total person-years of
observation, numbers of direct maternal deaths and
direct maternal mortality rates were estimated by HIV
status. Rate ratios, comparing direct maternal mortality
rates in WLHIV with those of HIV-negative women were
calculated using Poisson regression and were adjusted for
age, calendar period, residence and education. These
analyses were stratified by ARTavailability, with cross-site
comparisons based on results from the period when ART
was widely available. This analysis was conducted first
using all direct maternal deaths, and then using the more
restricted definition excluding anaemia. Person-years of
women who died but who did not receive a verbal
autopsy, were dropped from these analyses; however, we
undertook a sensitivity analysis assuming all HIV-negative
deaths missing a verbal autopsy were direct maternal
deaths, and no HIV-positive deaths were direct maternal.
This sensitivity analysis provides the most conservative
estimates of the association between HIV and direct
maternal mortality. For the Karonga DSS, we were also
able to evaluate the sensitivity of our results to the cause of
death attribution method as it is the only of the three DSS
that routinely interprets verbal autopsies using physician
review. In physician review, the signs and symptoms
reported in the verbal autopsy, and the narrative
description by the respondent of the events leading up
to the death are reviewed independently by two
physicians who assign a cause of death; discrepancies
between the two physicians are moderated by a third
physician, who assigns the final cause of death.
Pooled estimates of the association between HIV and
direct maternal mortality were calculated, combining the
adjusted rate ratios for the period since ART was widely
available from the three study sites. Estimates were pooled
using the DerSimonian and Laird method for random
effects meta-analysis. Evidence for between-study was
assessed using I2 and the P-value from the test
of heterogeneity.
Ethics and consent
Ethical approval for this analysis was granted by the
London School of Hygiene and Tropical Medicine ethics
committee (ref: 6522). Written informed consent was
provided by study participants (which is the family
member/caregiver of the deceased in the case of the
verbal autopsy) for the anonymized analysis of their data.
Results
Women aged 20–49 years contributed 235 291 person-
years of follow-up for this analysis across the three study
sites. In Karonga, there were 35 426 years of follow-up, all
of which fell in the ART widely available period. For
Kisesa, there were 77 408 person-years of follow-up:
31 112 in the ART widely available phase, 15 248 in the
early ART period and 31 048 before ART was available.
In uMkhanyakude, there were 96 647 persons-years of
follow-up when ART was widely available and 25 810
years in the early ART period, giving 122 457 person-
years overall.
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A total of 2186 verbal autopsies among women 20–49
could be assigned a cause of death. In Karonga, all deaths
identified in the DSS received a verbal autopsy (N¼ 158).
In Kisesa, 80.9% of the 570 deaths received a verbal
autopsy (N¼ 461) and in uMkhanyakude 96.4% of 1625
deaths did (N¼ 1567). Table 1 describes verbal autopsy
coverage and the number of verbal autopsies by key
characteristics of the population. The percentage of
verbal autopsies with known HIV status was 58% in
Karonga, 59% in Kisesa and 65% in uMkhanyakude.
When restricting analyses to the period in which ART is
widely available, we had 1346 verbal autopsies, with
uMkhanyakude contributing the most (N¼ 1065) and
Kisesa the least (N¼ 123).
The percentage of deaths attributed to direct maternal
causes amongst women 20–49 years varied between sites;
when ART was widely available, the percentages were
6.2% in uMkhanyakude, 12.7% in Karonga, and 18.3% in
Kisesa. The percentage of deaths attributed to direct
maternal causes was consistently higher amongst HIV-
negative women compared with WLHIV (Supplemen-
tary Figure 1, http://links.lww.com/QAD/B733). Com-
bining data for all periods, specific causes of direct
maternal deaths varied by HIV status between the sites but
there was no statistical evidence for differences in the
causes between WLHIV and HIV-negative women
(Supplementary Figure 2, http://links.lww.com/QAD/
B733). Amongst HIV-negative women, the most
common cause was obstetric haemorrhage in Karonga
and uMkhanyakude (12.5% and 3.6%, respectively), and
pregnancy-related sepsis in Kisesa (10.3%). For WLHIV,
the most common cause of direct maternal deaths was
obstetric haemorrhage in Karonga (3.9%), ectopic
pregnancy in Kisesa (3.7%) and anaemia of pregnancy
in uMkhanyakude (3.7%).
When ART was widely available, the direct maternal
mortality rate was 59.0 per 100 000 person-years in
uMkhanyakude [95% confidence Interval (CI): 45.5–
76.5], 79.0 in Karonga (95% CI: 54.6–114.5) and 80.4 in
Kisesa (95% CI: 54.3–118.9). Figure 1 and Supplemen-
tary Table 3, http://links.lww.com/QAD/B733 shows
these direct maternal mortality rates per 100 000 person-
years, by age group and HIV status. Direct maternal
mortality is generally higher among WLHIV, albeit with
large confidence bounds for some ages. Estimates of direct
maternal mortality rates in the pre-ART and early ART
period are provided in Supplementary Figure 3, http://
links.lww.com/QAD/B733. Mortality rates attributable
to non direct maternal causes of deaths are presented in
the Supplementary Materials, http://links.lww.com/
QAD/B733.
In all study sites, there was evidence that direct maternal
mortality was higher amongst WLHIVafter adjusting for
age, calendar period, residence and education (Table 2)
when ART was widely available. The magnitude of the
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higher rate of direct maternal mortality varied from 4.52
times in WLHIV in Karonga (95% CI: 1.62–12.63) to
5.92 in uMkhanyakude (95% CI: 2.30–15.21). Analysis
of earlier periods was only possible for Kisesa; there was
little evidence for a change in the rate ratio by ART
availability – when ARTwas not available, the rate ratio
was 4.36 (95% CI: 1.19–15.98) and in the early ART
phase, it was 4.91 (95% CI: 1.49–16.19). Only a single
direct maternal death was identified amongst HIV-
negative women in uMkhanyakude in the early ART
phase, negating the calculation of an adjusted rate ratio.
Removing anaemia of pregnancy did not change the
results when ART was widely available for Kisesa, but it
slightly reduced the rate ratio in Karonga (from 4.52 to
4.44) and substantially reduced it in uMkhanyakude from
5.92 to 1.39 (95% CI: 0.44–4.34, P-value¼ 0.4)
(Supplementary Table 4, http://links.lww.com/QAD/
B733).
Sensitivity analyses were undertaken in Kisesa and
uMkhanyakude, classifying HIV-negative deaths that
did not have a verbal autopsy completed as direct
maternal (Kisesa: two deaths with four person-years of
follow-up, uMkhanyakude: three deaths with 13 person-
years of follow-up) and HIV positive deaths without a
verbal autopsy as non obstetric (Kisesa: four deaths and
four person-years of follow-up). Although the association
between HIV and direct maternal mortality was
attenuated, there was still evidence for an association
(Supplementary Table 5, http://links.lww.com/QAD/
B733). In Karonga, there was a decrease in the adjusted
rate ratio when using physician review rather than
InSilicoVA to ascertain the cause of death, with the rate
ratio of direct maternal mortality in WLHIV compared
with their uninfected counterparts dropping from 4.23 to
3.31 (95% CI: 1.14–9.58) (Supplementary Table 6,
http://links.lww.com/QAD/B733).
The individual study and pooled estimates of the
association between HIV and direct maternal mortality
are given in Fig. 2. On the basis of data from the three
studies, we estimated that WLHIV have 5.23 times the
rate of direct maternal deaths than HIV-negative women
(95% CI: 2.89–9.45). There was no evidence of
between-study heterogeneity (I2¼ 0%, P-value¼ 0.93).
Discussion
Pooled estimates from the three study sites when ARTwas
widely available indicate that WLHIV aged 20–49 years
have over five times the rate of direct maternal mortality
compared with their uninfected counterparts, after
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Fig. 1. Direct maternal mortality rates per 100000 person-years by HIV status and age group in the period since ART became
widely available, for each study site. Cause of death assigned using InSilicoVA tool.
accounting for confounders including age and education.
This elevated risk of mortality from direct maternal
complications will account for a large percentage of the
excess mortality attributable to HIV in pregnant and
postpartum women identified in previous studies [4,5].
There was considerable variation between the study
populations in the percentage of deaths to women
attributed to direct maternal causes, from 6.2% in
uMkhanyakude to 18.3% in Kisesa. In all three study
sites, however, the percentages were higher than national-
level estimates from the 2016 Global Burden of Disease
(uMkhanyakude 6.2% versus South Africa 1.2%; Karonga
12.7% versus Malawi 5.8%; Kisesa 18.3% versus 12.4%
Tanzania) [21]. Due to the rural location of the study sites
and the basic level of healthcare available, this is not
surprising. Between-study differences were also observed
in rates of direct maternal mortality, with direct maternal
mortality rates lower in uMkhanyakude compared with
the other study sites. This is partly explained by the lower
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Table 2. Direct maternal mortality rates and rate ratios for direct maternal mortality by HIV status, study and antiretroviral therapy availability,
in women aged 20–49.
Number of direct
maternal deaths
Person
years
Rate
per 100 000
Crude
rate ratio
Crude
P-value
Age-adjusted
rate ratio
Age-adjusted
P-value
Adjusted
rate ratioa
Adjusted
P-valueb
ART widely available
Karonga
Negative 11 20 829 53 (29–95) 1 1 1
Positive 6 3229 186 (83–414) 3.52 (1.30–9.52) 4.10 (1.48–11.35) 4.52 (1.62–12.63)
Unknown 11 11367 97 (54–175) 1.83 (0.79–4.23) 0.05 1.80 (0.78–4.16) 0.03 2.02 (0.79–5.13) 0.02
Kisesa
Negative 8 14 322 56 (28–112) 1 1 1
Positive 5 1615 310 (129–744) 5.54 (1.81–16.94) 4.85 (1.57–14.93) 5.21 (1.68–16.12)
Unknown 12 15 174 79 (45–139) 1.42 (0.58–3.46) 0.03 1.46 (0.59–3.61) 0.04 1.67 (0.67–4.17) 0.03
uMkhanyakude
Negative 5 27 031 18 (8–44) 1 1 1
Positive 39 32 402 120 (88–165) 6.51 (2.56–16.51) 6.12 (2.40–15.60) 5.92 (2.30–15.21)
Unknown 13 37 214 35 (20–60) 1.89 (0.67–5.30) <0.001 1.86 (0.66–5.23) <0.001 1.94 (0.68–5.50) <0.001
Early ART
Kisesa
Negative 9 8956 100 (52–193) 1 1 1
Positive 4 682 587 (220–1564) 5.84 (1.80–18.97) 5.37 (1.65–17.54) 4.91 (1.49–16.19)
Unknown 9 5610 160 (83–308) 1.60 (0.63–4.02) 0.04 1.60 (0.63–4.09) 0.05 1.59 (0.62–4.10) 0.06
uMkhanyakudeb
Negative 1 7107 14 (2–100) 1 - -
Positive 4 4109 97 (37–259) 6.92 (0.77–61.90) - -
Unknown 14 14 595 96 (57–162) 6.82 (0.90–51.84) 0.04 - - - -
ART not available
Kisesa
Negative 11 17 133 64 (36–116) 1 1 1
Positive 3 1163 258 (83–800) 4.02 (1.12–14.40) 4.06 (1.13–14.59) 4.36 (1.19–15.98)
Unknown 9 12 751 71 (37–136) 1.10 (0.46–2.65) 0.18 1.18 (0.49–2.87) 0.18 1.27 (0.51–3.14) 0.16
ART, antiretroviral therapy.
aAdjusted for age group, calendar period, residence and education level in Karonga and uMkhanyakude. In Kisesa, estimates are adjusted for age
group, calendar period and residence.
bAdjusted rate ratios were not calculated due to small numbers, notably amongst the HIV-negative group.
Fig. 2. Association of HIV and direct maternal mortality since ART became widely available, for each of the study sites and the
pooled estimate calculated from random-effects meta-analysis.
levels of fertility in South Africa [22]. Another important
factor is healthcare systems, with many more births
occurring in health facilities with skilled birth attendants
in South Africa, compared with Malawi and Tanzania
[23].
Exploring specific causes of direct maternal deaths is
limited by the small number of deaths in each study site,
and the challenges of assigning specific causes of death
using verbal autopsy. There are, however, a number of
biological pathways that may explain the elevated
mortality from direct maternal complications in WLHIV.
Immune suppression associated with HIV is likely to leave
WLHIV more vulnerable to pregnancy-related sepsis
[24,25]. Studies have also documented an increased risk of
pregnancy-related anaemia in WLHIV in sub-Saharan
Africa [26,27], but the cause behind this is complex:
causes of anaemia include blood loss and ineffective red
blood cell production because of deficiencies in iron,
which are independently linked both to HIV and
pregnancy [28]. Co-infection with malaria, which is
more common and more severe amongst pregnant
WLHIV [29], likely plays a role in increasing anaemia,
particularly in Kisesa where malaria is a leading cause of
death [16]. Blood loss during delivery may be more severe
for WLHIV because of HIV-related thrombocytopenia;
lower platelet counts in the blood can lead to problems in
coagulation causing higher levels of mortality because of
haemorrhage and anaemia. There are very few epidemi-
ological studies looking at the link between HIV and
thrombocytopenia in pregnant women, and these yield
conflicting results [30,31].
Poor access to, and quality of, healthcare may also increase
the risk of mortality from obstetric complications in
WLHIV. Studies have generally shown similar or better
engagement with ANC amongst WLHIV compared with
HIV-negative women in sub-Saharan Africa [32,33]. The
evidence linking HIV and poor-quality maternity care is
scant. In studies conducted in four maternity hospitals in
Kisumu (Kenya) and one large referral hospital in Dar es
Salaam (Tanzania), healthcare workers reported that they
were trained to treat WLHIV in the same way as HIV-
negative women [34,35]. However, in the Kenyan study,
several providers reported that knowing a woman is HIV-
positive would lead them to handle a woman with ‘extra
care’, and in both settings, providers mentioned that
WLHIV may have not have received the same care as HIV-
negative women in the past [34,35]. A study describing the
prevalence of disrespect and abuse during labour and
delivery in 40 facilities across Malawi found that, through
observation of over 2000 deliveries, WLHIV were less
likely to be asked about their preferred delivery position or
other problems she might be concerned about [36].
There are a number of limitations that need to be
considered when interpreting the results. Firstly, it is well
recognized that verbal autopsies are imprecise, and cause
of death misclassifications are inevitable. We may have
overestimated the association between HIV and direct
maternal mortality if HIV/AIDS-related deaths have
similar symptom patterns as some direct maternal deaths.
This is possible for deaths that were attributable to
anaemia and ectopic pregnancy but unlikely for most
other direct maternal causes that have relatively distinctive
symptom patterns. Removing anaemia of pregnancy
from our definition of direct maternal deaths did not
change our conclusions in Karonga and Kisesa but led to a
drop in the rate ratio for uMkhanyakude such that there
was no longer evidence of a difference in direct maternal
mortality in WLHIV and HIV-negative women. Sec-
ondly, there are limitations in using algorithms to assign
cause of death using verbal autopsy data. Critically, they
do not use information from the narrative section of the
verbal autopsy where the respondent gives their own
account of the events leading up to the death. Finally,
some of the association we observe may be because of
residual confounding. For example, whilst we adjusted for
education and area of residence, this may not be sufficient
to account for socioeconomic differences between
WLHIV and HIV-negative women that may lead to
differences in risk of mortality from direct maternal
complications. We also lacked data on other infections.
Other STIs, for example, are more likely to occur in
WLHIV and may leave women at increased risk of
complications [37].
We considered direct maternal mortality rates amongst
women of reproductive age, rather than focussing on just
the subset of pregnant and postpartum women because of
data availability. Notably, we lacked comprehensive data on
dates of pregnancy and pregnancies that did not result in a
livebirth across some of the study sites. HIV lowers fertility
in the age groups under consideration, therefore our
estimates of the rate ratio comparing obstetric mortality in
WLHIVand HIV-negative women will be lower than if we
had calculated the rate ratio amongst only women who
became pregnant. However, we expect that the rate ratio is
unlikely to be much larger for women who become
pregnant. Previous studies utilizing DHS [11] or data from
the same study sites [10,38] show that, with ART, the gap in
fertility rates between HIV-positive and negative women is
narrowing slightly compared with the pre-ART era;
however, some differences in fertility remain.
We find consistent evidence across the study sites
suggesting HIV increases the risk of direct maternal
mortality. This has implications for the measurement of
HIV/AIDS mortality, as well as for service provision for
pregnant and postpartum WLHIV. When measuring the
impact of HIV/AIDS on mortality using verbal autopsy
data, it is insufficient to rely on the number of deaths that
are directly classified as HIV/AIDS. Measurement should
account for the percentage of deaths that are attributable
to HIV but not explicitly classified as such. These results
also suggest we are failing to deliver quality maternity
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services to WLHIV, who are at elevated risk of this largely
preventable cause of mortality. Understanding the relative
importance of the pathways that leave WLHIV at
increased risk of direct maternal mortality (e.g. biological
increase in risk of anaemia/sepsis, and healthcare system
or behavioural barriers to receiving quality care) would be
useful. WLHIV may need closer monitoring for
complications, such as sepsis, and barriers that WLHIV
face barriers in accessing quality antenatal, delivery and
postnatal care should be addressed.
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